There is not sufficient comparative data to permit a full assessment of the role of the fibrinolytic mechanism as a counterbalance to coagulation throughout the animal kingdom. In all vertebrate animals, hemostasis involves the production of fibrin clots, but little is known about the part played by fibrinolysis in the subsequent fate of the fibrin in animals other than man and the more common laboratory mammals.
Three species of fish have been studied in detail (Doolittle & Surgenor 1962) . No fibrinolytic activity has been found in the lamprey (Petromyzon marinus) or the blackfish (Tautoga onitis), but in the smooth dogfish (Mustelis canis) complete lysis of whole blood clots occurs in 2-4 hours. Lysis of whole blood clots implies either that the lytic activity is very high or that the blood contains no fibrinolytic inhibitors. This second possibility is supported by Niewiarowski & Latallo (1959) , who were unable to demonstrate inhibition of human plasmin by fish blood.
Fibrinolytic activity cannot be induced in fish blood by any known plasminogen activator, so in this class of animals the presence of an inactive fibrinolytic precursor is as yet unproven.
Amongst the amphibians, the marine toad (Bufo marinus) and the tree frog (Hyla cwrula) also show spontaneous lysis of whole blood clots (Hackett & LePage 1961 , Hackett & Hann 1964 . In the common frog (Rana temporaria), the leopard frog (R. pipiens) and the clawed toad (Xenopus lkvis), whole blood clots do not lyse but spontaneous lysis can be revealed if steps are taken to remove inhibitors (Blofield 1965 (Blofield , 1971 ). These findings show that in all five species a fibrinolytic enzyme is present and suggest that, in the latter three, inhibitors also exist. In xenopus, fibrinolysis is greatly enhanced by human urokinase (UK), or streptokinase plus human serum (SKHS), indicating the presence of a plasminogen-like precursor. Thus in this representative of the Amphibia the fibrinolytic mechanism is similar to that of man.
Reptiles are unusual amongst the vertebrates in that the normal blood clotting time is comparatively prolonged. This is attributed to the presence of a potent circulating anticoagulant which is thought to protect these animals from intravascular thrombosis which might occur as a result of their slow circulation and sluggish way of life (Hackett & Hann 1967) . There is no evidence of a fibrinolytic mechanism in these animals (Hawkey 1970) ; possibly a clot-lysing mechanism is rendered unnecessary by the clotting inhibitor.
Spontaneous fibrinolysis has not been detected in the blood of domestic birds (Niewiarowski & Latallo 1959), but in some wild birds spontaneous activity after removal of inhibitors has been found (Hawkey 1970) . Activation cannot be achieved with UK, SK or SKHS (Cliffton & Cannamela 1951) , but in some domestic birds the fibrinolytic mechanism is activated by saliva from the bird-feeding vampire bat (Dikmus youngi) (Cartwright & Hawkey 1969) . Thus a fibrinolytic enzyme, an inactive precursor and inhibitors are present in at least some animals of this class.
Fibrinolytic studies on mammals have shown that the same components are present as in man. In this class of animals some quantitation of results (Table 1 ) and the situation is simplified by the fact that, in all mammals, plasminogen is activated by UK and SKHS, and in some by SK alone. The most variable factor is the level of circulating plasminogen activator. This cannot be correlated with plasminogen or fibrinogen levels or with observed stress or use of any anesthetic or tranquillizing drug but, broadly speaking, closely related mammals have similar activator levels. In some species, for example elephants and some bovine animals, the level of circulating plasminogen activator is immeasurably low in spite of the stress situation induced by taking blood samples. The highest levels have been found in new world monkeys (Cebida); these animals also show a rapid generation of intrinsic prothrombin activator and high concentrations of some clotting factors (Hawkey 1971 ) so, in this group, clotting and fibrinolytic activity are apparently increased in parallel. The average plasminogen level in monkeys and carnivores is higher than in man, implying greater potential fibrinolytic activity in these animals. As a general rule the plasminogen level in Artiodactyla is low. Free plasmin has not been detected in any mammal so far examined. Inhibitors of fibrinolysis are present in all mammals, and in monkeys and carnivores the average values of these do not differ significantly from those of man.
Considering these findings from an evolutionary point of view, a fibrinolytic enzyme has been identified in animals as far back as the cartilaginous fish, and at this stage it seems possible that inhibitors of the mechanism have not yet been developed. There is no evidence of an activator/ proenzyme stage in fish. Inhibitors are also apparently absent in some amphibians but in the clawed toad the full spectrum of fibrinolytic factors has been identified. Reptiles are odd in that they have no fibrinolytic mechanism but, in these animals, blood coagulation is held in check by the presence of a circulating anticoagulant. In birds the same fibrinolytic factors are present as in mammals although in some birds spontaneous fibrinolytic activity has not been found.
Methodological difficulties may account at least partially for our current inability to detect fibrinolysis in all animals capable of producing a fibrin clot (Hawkey 1970) . In mammals, where these are less evident, a parallel increase in both clotting and fibrinolysis has been demonstrated in new world monkeys, and many mammals which are 'hypercoagulable' compared with man also have higher plasminogen levels. At present the physiological pathways by which the fibrinolytic mechanism is activated in non-human species are not fully understood. Elucidation of these together with the collection of more comparative data is necessary before the physiological implications of the coagulation/fibrinolysis equilibrium can be fully assessed.
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Fibrinolysis in Pregnancy
It is an interesting clinical fact that pregnant women may be especially prone to what can best be described as episodes of uncompensated disseminated intravascular coagulation, which lead to microcirculatory blockade. The clinical features of this phenomenon are variable but include acute renal cortical necrosis, acute renal
